Market Signal Briefing

It's been a tough past couple of years for Constellation Brands (STZ +1.10%) shareholders. The stock's down more than 50% from its early 2024 peak, and seemingly still moving lower. The end of the COVID-19 pandemic's worst and the beginning of an inflation-riddled period is taking a double-barreled toll on alcohol consumption. Not only are people drinking less of it for health-minded reasons, but for cost-related reasons as well.

The sellers, however, have arguably overshot their target, ignoring how the company's foreseeable future looks much better than its recent past. This budding turnaround makes the pullback an attractive entry opportunity for patient investors.

Constellation Brands is on the defensive
You may know the company better than you think. Constellation is parent to popular beer brands Modelo and Corona, which account for the bulk of its revenue. It also owns a handful of smaller wine brands, like Kim Crawford and Ruffino, as well as spirits like High West whiskey and Mi Campo tequila.

The $23 billion company did $10.2 billion worth of business last fiscal year, up slightly from the previous year's top line.

Today's Change

(

1.10

%) $

1.49

Current Price

$

136.38

That would be the end of a respectable growth streak, though. Sales are down 10% through the six-month stretch ending in August. Gross profits and operating profits are similarly lower, mostly thanks to "a difficult socioeconomic environment that dampened consumer demand across the industry."

That's not an inaccurate explanation. The Beer Institute reports that through September, shipment volume is down 5%, jibing with data from the Brewers Association. Separately but simultaneously, a recent survey from Gallup confirms the business' worst fears -- a record-low 54% of American adults are now regular drinkers, with a majority of this crowd citing health concerns as their top reason for cutting back.

To this end, Constellation Brands' guidance for the full year ending in February suggests a 4% to 6% top-line dip, leading to a slightly bigger decline in operating income.

STZ Revenue (Quarterly) data by YCharts.

The bullish case
But things are about to change in a way the market isn't pricing in -- or even seeing -- yet. In simplest terms, think of 2025 as a reconfiguration year for Constellation Brands. It's rebuilding a better business for what should (hopefully) be a better business environment.

Chief among these changes so far is the decision made earlier this year to shed certain wine brands with lower price points. Although wine isn't a particularly big piece of the company's revenue, as CEO Bill Newlands explained of the move, "concentrating our wine and spirits portfolio in higher-growth segments remains an important element of our overall business strategy and complements our higher-end beer portfolio."

He's right. While overall alcohol consumption is down, higher-end alcohol consumption is up, even if only modestly. This bodes well for Constellation's breadwinning beer brands Modelo and Corona, neither of which are priced out of reach for most beer drinkers, but both of which are clearly priced above most baseline beers.

Image source: Getty Images.

Then there are the company's more operationally minded efforts. In Newlands' words, spoken at Barclays' recent consumer staples company conference, Constellation is "controlling the controllables." This includes plans to cull $200 million worth of unnecessary annual spending by the end of fiscal 2028. For perspective, the analyst community expects the company to earn $1.86 billion this year.

Perhaps the most compelling reason to step into this stock while it's down, however, is the cyclical swing that's not evident yet, but sure to be brewing. That's a rebound of the broad beer business driven by rekindled economic strength. If there's one thing veteran investors know, it's that everything ebbs and flows, including different categories of consumer goods. These same veteran investors also know the turnaround often takes shape with little to no warning.

In the meantime, newcomers will be plugging into this stock while its forward-looking dividend yield stands at just over 3%. That's not a bad way to start out a new trade.

More reward than risk
This is certainly no guarantee that Constellation Brands shares are ready to soar. There's no guarantee that they've even hit their ultimate low. There's risk here, to be sure.

With a forward-looking price-to-earnings ratio of less than 20 for a company that's usually profitable though, most of any risk has likely been wrung out. It may not be your highest-growth prospect, but it's certainly not your most dangerous.

More than anything, you're buying into one of the highest-quality companies in an industry with proven long-term staying power. Alcohol's current headwind isn't going to last forever. You'll want to dive in during the headwind when the stock's beaten up -- not after the recovery is well underway.

This might help. Although the stock's been a poor performer for a while, the analyst community isn't discouraged. They're actually becoming more bullish. Most of them are calling Constellation a buy, with a consensus price target of $169. That's 28% above the stock's present price, which isn't a bad way to start out a new trade.

November 29, 2025 5:31 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 29, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period"), of the important January 9, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Telix securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Telix class action, go to https://rosenlegal.com/submit-form/?case_id=43778 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 9, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) defendants materially overstated the quality of Telix's supply chain and partners; and (3) as a result, defendants' statements about Telix's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Telix class action, go to https://rosenlegal.com/submit-form/?case_id=43778 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276057

November 29, 2025 5:35 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 29, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Avantor common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Avantor class action, go to https://rosenlegal.com/submit-form/?case_id=47303 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than December 29, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants misrepresented and/or failed to disclose that: (1) Avantor's competitive positioning was weaker than defendants had publicly represented; (2) Avantor was experiencing negative effects from increased competition; and (3) as a result, defendants' representations about Avantor's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Avantor class action, go to https://rosenlegal.com/submit-form/?case_id=47303 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276055

Here's how to invest in the latest tech trends without trying to pick winners on your own.

The technology sector is booming right now, largely due to the monumental growth of artificial intelligence (AI). But picking long-term tech winners is notoriously difficult, and it can be safer to spread your money out among many companies.

That's what makes buying a technology exchange-traded fund (ETF) a good idea. You'll be invested in a variety of leading tech players and benefit regardless of who dominates. You can also invest just $100, or even less, depending on which brokerage you use.

If this sounds appealing to you, here's why buying the Vanguard Information Technology ETF (VGT +0.71%) is a great place to put your money right now.

Image source: Getty Images.

Tech will likely dominate the market's returns for years to come
The Vanguard Information Technology fund spreads its investment across 300 small- and large-cap technology companies, tracking the MSCI US Investable Market Information Technology 25/50 Index. This provides investors with exposure to a range of top semiconductor and software companies, including Nvidia and Microsoft.

The fund currently has more than 51% of its holdings in semiconductor and software companies, with the remainder comprising tech hardware, application software, communications equipment, and other related industries. Not only is this significant diversification, but because the fund is invested in both large and small-cap companies, you won't miss out on owning rising disruptors in the industry.

It is also important to note that technology stocks have been a dominant force in the stock market's rise, essentially since the 1990s. The AI boom is the latest iteration of technology's influence on the market, and there's no end in sight for the influence of technology stocks.

The result has been very positive for investors who own the Vanguard Information Technology ETF. The fund has had an average annual return of 14.4% since its inception in 2004.

Of course, there's no guarantee it will continue at that pace. Still, it's an indicator of how well the fund can perform when technology companies are benefiting from long-term opportunities, such as the early days of the internet, mobile devices, and now AI.

The fund won't steal your returns
One thing to remember when choosing an investment fund is that all of them charge an expense ratio. This is a small fee that you pay annually to cover the costs of the investment firm managing the fund.

ETF expense ratios are often less expensive than mutual fund fees, so you're already ahead if you're considering an ETF. But you'll do even better by choosing a Vanguard ETF because its funds have some of the lowest expense ratios in the industry.

Today's Change

(

0.71

%) $

5.27

Current Price

$

752.20

The Vanguard Information Technology ETF is no exception, charging an expense ratio of just 0.09% -- significantly lower than the average fee of 0.94% for similar funds. That means if you have $10,000 invested in this fund, you'll only pay $9 in annual fees. 

With such low fees, you'll be able to keep more of the gains you earn over time, making your investment much more profitable than if you were to buy a more expensive fund with similar returns.

The same buy-and-hold rules for stocks apply to ETFs
It's important to remember that when buying an ETF, you should apply the same buy-and-hold strategy to owning it as you would any stock. Jumping in and out of funds when they rise and fall is a good way to diminish your potential returns.

Instead, consider buying the Vanguard Information Technology ETF and holding it for at least five years, ideally longer, and add to it when possible. Do that for years, and you'll be well on your way to building a strong portfolio.

The struggling pharmaceutical giant is showing signs of life.

Over the past 18 months, Merck (MRK +0.19%) shares have been mostly southbound as the drugmaker encountered several headwinds. Its vaccine business isn't performing as well as expected, resulting in lower revenue growth than anticipated. Furthermore, there are a growing number of mid- or late-stage clinical candidates that could challenge the dominance of Keytruda, its blockbuster cancer drug.

However, Merck has been working hard to navigate these headwinds. Recent developments have given the company's prospects -- and share price -- a boost. Let's find out what those are, and what they could mean for investors.

Merck records an important mid-stage win
In 2021, Merck acquired Acceleron Pharma, a smaller drugmaker, for $11.5 billion. The key asset from the transaction was sotatercept, which was, at the time, an investigational medicine for pulmonary hypertension (PH, a type of high blood pressure in the lungs).

Sotatercept has since earned approval, is marketed under the brand name Winrevair, and is indicated to treat a specific type of PH called pulmonary arterial hypertension (PAH), which happens when blood flow in the lungs is disrupted due to the narrowing of blood vessels. Winrevair is performing pretty well so far. The medicine was approved just last year and has generated $976 million through the first nine months of 2025.

Image source: Getty Images.

However, there could be even more in store for this compound. Merck recently announced that sotatercept successfully completed a phase 2 study in patients with combined post- and precapillary pulmonary hypertension (CpcPH) due to heart failure with preserved ejection fraction (HFpEF). In simpler terms, that's when a patient develops two causes of PH at the same time (a subset of Group 2 PH, one of the more common forms of the disease).

This mid-stage win is a big deal for Merck. CpcPH due to HFpEF is classified as rare, but as the company pointed out, it's believed to be underdiagnosed. And right now, there are no treatments approved specifically for CpcPH. So Merck is targeting a specialist market, where it may not face much direct competition if sotatercept passes phase 3 studies and earns this label expansion.

Even with only around 100,000 patients -- which is well in the ballpark of "rare" -- the medicine could achieve significant success in this indication. It could add over $1 billion to the annual sales potential of sotatercept. That's why Merck's shares jumped on the news. The company might soon encounter competition, whether from biosimilars or otherwise, for Keytruda. But sotatercept's progress is giving the market confidence that it will be a key asset in helping Merck move beyond its current crown jewel.

There's even more good news
Several other developments bode well for Merck's prospects. Let's consider two.

First, the company recently announced that it would acquire Cidara Therapeutics (CDTX +0.06%) , a mid-cap biotech company, for approximately $9.2 billion in cash. Merck will get access to CD388, a potential therapy that could disrupt the influenza market. Current flu vaccines have significant drawbacks, including low or waning efficacy as the season progresses. They can also be less effective in some of the people who need them the most: the elderly and the immunocompromised.

CD388 seeks to address all these shortcomings. The medicine has performed well in phase 2 studies, and it could become an important addition to Merck's portfolio.

Today's Change

(

0.19

%) $

0.20

Current Price

$

104.83

Second, Merck is inching closer to another brand-new launch. The company's combination of doravirine and islatravir is being studied for treating HIV and is awaiting approval from the U.S. Food and Drug Administration, which could come down sometime early next year. It could be yet another product that will help Merck's post-Keytruda plans.

It's also worth pointing out that Merck has received approval for a subcutaneous version of Keytruda. Though lacking all the original version's indications, this new formulation won't face a patent cliff anytime soon. As Merck combines subcutaneous Keytruda with newer products like Winrevair, its potential HIV treatment, and Capvaxive -- a pneumonia vaccine that earned approval last year and generated $244 million in sales in the third quarter -- it should be able to get past the challenges to its core franchise.

Is the stock a buy?
The drugmaker may face more challenging days ahead as it navigates current issues with its vaccine business. However, it's showing why it has performed well for a very long time. Merck's deep pipeline and ability to identify attractive opportunities should allow it to perform well over the long run, despite the obstacles it faces.

Finally, Merck is a terrific dividend stock that has increased its payouts by 84.7% over the past decade and currently offers a forward yield of 3.5%. It may not be a stock to buy for explosive growth, but it is an excellent, reliable blue chip income stock to add to your portfolio.

TLDR:

Ethereum price is coiling tightly, with RSI breakout signaling possible near-term movement.
RSI movements often lead Ethereum price, pointing to a potential $3,400 test.
FUSAKA upgrade scheduled for Dec 3, 2025, may influence market trends.
Historical Pectra upgrade showed 55% gain in 35 days and 168% in 109 days.

Ethereum is showing early technical signals ahead of the FUSAKA upgrade. 

The cryptocurrency is trading in a tight range, indicating low volatility. The Relative Strength Index (RSI) has already broken out. Price action is currently lagging behind momentum indicators.

The RSI breakout suggests potential movement in the near term. Analysts are noting that Ethereum may test higher levels. Technical indicators are being closely monitored. Traders are observing the coiling price pattern for signs of a breakout.

Ethereum’s price is coiling tightly, suggesting a period of consolidation. According to Merlijn The Trader, “Price is coiling tight. RSI already broke out. Moves like this don’t stay quiet for long.” RSI movements often precede price changes. Momentum indicators are signaling possible upcoming activity.

EARLY SIGNALS FROM ETHEREUM?

Price is coiling tight.
RSI already broke out.
Moves like this don’t stay quiet for long.

Price lags. RSI leads.
If Ethereum follows, $3.4K is the next test.

Momentum is shifting. Eyes on $ETH. pic.twitter.com/YFdz5eM3xm

— Merlijn The Trader (@MerlijnTrader) November 29, 2025

The breakout in RSI points to potential price tests. Ethereum’s price tends to lag behind RSI movements. Observers are identifying $3,400 as a possible next level if momentum continues. Technical setups are being closely tracked.

Merlijn notes that momentum is shifting, which could influence near-term price action. RSI is considered a leading indicator in technical analysis. Traders are watching consolidation and breakout patterns. Indicators provide signals ahead of price changes.

FUSAKA Upgrade Could Influence ETH Price Action
The FUSAKA upgrade is scheduled for December 3, 2025. Crypto Patel highlighted that the previous Pectra upgrade on May 7, 2025, triggered notable gains for Ethereum. Data shows a 55% increase within 35 days and 168% in 109 days post-upgrade. Historical patterns are being analyzed for potential trends.

$ETH Could Skyrocket to $7.8K After FUSAKA Upgrade – History Shows

The last Ethereum Pectra Upgrade on 7 May 2025 triggered a massive move:
✅ +55% in 35 days
✅ +168% in 109 days

What’s next?
The FUSAKA Upgrade is scheduled for 3 December 2025. If history repeats:

👉 Target… pic.twitter.com/ojZXLQSYWZ

— Crypto Patel (@CryptoPatel) November 29, 2025

Using the Pectra fractal as a reference, post-FUSAKA targets are $4,500 by January 7, 2026, and $7,800 by March 22, 2026. These projections are based on prior upgrade movements. Traders are observing these levels for reference. The FUSAKA upgrade may influence market behavior in the near term.

Crypto Patel advises that market reactions can vary despite historical trends. Observers continue to track Ethereum’s price and technical indicators. The FUSAKA upgrade is a focal point for upcoming activity. Market data is being analyzed in real time.

Ethereum is showing technical signals alongside an upcoming network upgrade. Price may test higher levels if current momentum continues. 

Arthur Hayes, co-founder of crypto derivatives exchange BitMEX, has warned that most Layer 1 blockchain tokens outside Ethereum and Solana are unlikely to survive long-term. In an interview with Altcoin Daily, he argued that many newly launched networks, despite attracting early investor attention, lack sustainable fundamentals and carry inflated valuations. Hayes emphasized that initial hype often creates short-term price gains but does not guarantee enduring success for these projects.

Monad and the Risks of High-Valuation L1sHayes specifically highlighted Monad, a recently launched L1 backed by Coinbase Ventures. At the time of his statement, MON token had risen 45% since its ICO, reaching roughly $0.037 with a market capitalization near $398 million. 

Despite these gains, Hayes expects a dramatic decline, citing the coin’s high fully diluted valuation and low circulating supply. He noted that many new L1s follow a pattern of early surges followed by sharp corrections, driven by initial investor optimism rather than fundamental value.

According to Hayes, new L1 projects often attract attention because investors hope to discover the next Ethereum. Early pumps create excitement, but most tokens fail to maintain momentum once hype fades. 

Venture capital support may temporarily prop up prices, but Hayes warned that this does not guarantee long-term success. Consequently, he believes most L1 tokens outside Ethereum and Solana are destined for collapse.

Ethereum and Solana: The Standout NetworksDespite the challenges facing newer L1s, Hayes identifies Ethereum and Solana as exceptions. He sees Ethereum as the foundation for institutional blockchain adoption. 

Large banks and organizations now prefer public networks over private chains due to security and utility advantages. Layer 2 solutions like Arbitrum and Optimism will help Ethereum scale while maintaining privacy, positioning it for sustained growth.

Solana, according to Hayes, remains the second-largest L1, benefiting previously from meme coin activity. However, he acknowledges that meme-driven growth has slowed. 

Solana will need a new catalyst to maintain user engagement and price momentum. While Hayes remains skeptical that it will surpass Ethereum, he believes the network will continue to play a significant role in the blockchain ecosystem.

Hayes’ Magnificent FiveIn addition to Ethereum and Solana, Hayes named Bitcoin, Zcash, and Ethena as his top cryptocurrency picks. These networks combine adoption, security, and practical utility, which he considers critical for long-term success. By contrast, most other L1 tokens face a high risk of decline as early enthusiasm fades.

2 hours ago

The Hyperliquid development team provided clarity on Saturday's token unlock in response to community fears of increased selling pressure.

The team behind the Hyperliquid decentralized exchange (DEX) disclosed a 1.75 million HYPE token unlock for its developers and core contributors on Saturday, valued at over $60.4 million at the time of this writing.

Saturday’s token unlock was previously announced and is part of HYPE’s vesting schedule, according to pseudonymous Hyperliquid developer iliensinc, who celebrated the first anniversary of Hyperliquid’s historic airdrop and token generation event. He said:

“For perspective, about 270 million tokens were fully unlocked on Nov 29, 2024, in the largest airdrop in history, measured in today's market value at about $9.5 billion. There are no investor unlocks, as Hyperliquid never raised any external capital.” Source: iliensincThe unlock sparked fear about potential selling pressure that could impact HYPE’s market price, which declined by about 4.6% at the time of this writing.

Hyperliquid’s airdrop and token generation event was considered a landmark debut in the crypto industry that changed product launches, by touting a community-focused model, rewarding early adopters, developers, and users, as opposed to venture capitalists.  

Hyperliquid’s token unlocks are already priced in“Even if the team pinky swears to not sell, there is nothing holding them to that,” founder of the BitMEX crypto exchange and market analyst Arthur Hayes said.

HYPE token holders must expect a non-zero chance of daily selling pressure, which has already been priced in by the market, reflected in HYPE’s decline since September, Hayes added.

The price of HYPE has declined by about 42% from its all-time high of about $59.40, reached in September, and is trading well below its 200-day moving average, a critical support level.

HYPE’s price action shows a steady uptrend, culminating in an all-time high in September, followed by a decline. Source: TradingViewHYPE started falling on September 19, before the historic market crash in October that wiped away up to 95% in value from certain altcoins.

The token fell by about 54% in a single day during the October 10 market crash but rebounded to the $40 level within two days of the crash.

Analysts and crypto industry executives have praised Hyperliquid for its revenue generation and the platform’s ability to handle $330 billion in monthly trading volume with a small development team.

Magazine: Astrology could make you a better crypto trader: It has been foretold

Conversations around XRP have grown louder in recent weeks as the cryptocurrency continues to trade around the $2.2 region while new Spot XRP ETFs continue to attract inflows across multiple issuers. 

One voice in the community has attempted to explain why the market is unusually calm despite rising institutional demand. An XRP enthusiast known as Pumpius shared a detailed thread on X that breaks down the mechanics behind the new ETFs and why the real impact may still be ahead. His argument is that the current XRP price action does not yet reflect what is going on behind the scenes.

Why ETF Rules Create A Special Market Dynamic
Pumpius explained that the foundation of the entire setup is in one legal detail with fund managers. ETF fund managers are restricted from purchasing XRP directly from Ripple or from the escrow accounts that hold large reserves of the token. Every ETF must source XRP through open-market purchases, without private deals or wholesale arrangements.

The absence of direct acquisition forces institutional buyers into the same liquidity pool as retail and whales. With the new launch of XRP ETFs, and as demand continues to rise, the circulating supply is now the battleground, and this mechanical pressure is already visible in recent weeks as XRP trading volumes climbed while exchange supply began trending downward. 

According to market trackers, XRP supply on major exchanges has declined steadily since the approval of the first Spot XRP ETFs, showing that the stress on available liquidity is not theoretical but active. Particularly, data from CryptoQuant shows that Binance’s XRP reserves are now at their lowest point in months, having dropped to 2.7 billion tokens this week.

XRPUSD currently trading at $2.18. Chart: TradingView
Incoming Supply Squeeze For XRP
Another part of the explanation focuses on Ripple’s behavior regarding escrow releases. Although one billion XRP is unlocked each month, Ripple has repeatedly returned about 700 million to 800 million of these unlocked  tokens back into escrow. 

Ripple releases only what it considers necessary to maintain healthy liquidity in the ecosystem, and the company has avoided significant selling pressure since the ETF approvals.

According to Pumpius, this means the ecosystem is operating in a controlled balance where ETF issuers are absorbing a growing share of the circulating float, while Ripple keeps escrow output extremely conservative. 

The result is a slow tightening of supply that’s happening behind the scenes and may not yet be visible in price action but can eventually cause what he called a structural supply shock. When this happens, XRP will not move slowly, but it will break price levels with impact.

Still speaking of what is happening behind the scenes, Ripple has been advancing several developments that could strengthen XRP’s long-term position. A recent example is Abu Dhabi’s financial regulator formally recognizing RLUSD as a fiat-referenced token.

Featured image from Unsplash, chart from TradingView

Key NotesSolana price holds above $135 despite 21Shares withdrawing its SOL staking ETF application.Derivatives data shows $12.5 million in bullish leverage added as traders counter bearish headlines.Solana ETFs swung back to $5.3 million inflows on Friday, signaling improving sentiment after Thursday’s $8.3 million drawdown.
Solana price found firm support above $135 on Saturday, Nov. 29, positioning the asset to close the week with roughly 6% gains despite bearish sentiment triggered by 21Shares withdrawing its Solana staking ETF application, citing challenges in completing regulatory obligations.

Solana open interest rises 1.7% as bulls defend $135 support after 21Shares withdrew its application for SOL ETF staking. | Source: Coinglass

Resilience from bull traders cushioned the downside impact, with Coinglass data showing Solana open interest rising 1.7%, even as SOL price dipped 1.25% intraday in the spot markets. This indicates that speculative traders added $12.5 million in notional leverage to defend the $135 price support level.

Solana’s funding rate also flipped positive to hit 0.0027% on the 8-hour time frame, showing the bulls are paying higher fees to keep bullish positions open.

The long-to-short ratio, hovering near 1.0, confirms that most of these new positions came from bullish market participants covering aggressively rather than from shorts piling in.

Solana ETF Flows as of Nov 28, 2025 | Source: FarsideInvestors

ETF flows also reinforced the resilience narrative. All actively traded Solana ETFs closed the week positive, recording $5.3 million inflows on Friday, reversing Thursday’s $8.3 million outflow that ended a 22-day inflow streak dating back to SEC approval on Feb. 28. The return to net inflows suggests traders expect the 21Shares ETF headwind to fade quickly.

Solana Price Forecast: Can Bulls Confirm the Falling Wedge Breakout Toward $220?
Solana continues to trade inside a well-defined falling wedge, a bullish reversal pattern formed when descending support and resistance lines converge. A breakout typically occurs when the price closes above the upper trendline, often triggering a rally proportional to the wedge’s height.

Solana is currently trading around $135–$136, sitting between the KC midline and lower band. A positive MACD crossover reflects improving trend strength and rising upside probability.

Solana (SOL) Technical Price Analysis | Source: TradingView

The falling wedge projection on the SOLUSD daily price chart shows upside potential of 62.24%, targeting the $220 level, if a confirmed breakout occurs above the wedge’s upper boundary near $150. Conversely, downside risk is marked at 29.13%, referencing a potential retest of wedge support near $120.

On the upside, a daily close above $143.10 followed by a breakout above $150–$152 would complete the falling wedge structure. If this occurs, Solana could accelerate toward the $200–$220 measured-move target.

Disclaimer: Coinspeaker is committed to providing unbiased and transparent reporting. This article aims to deliver accurate and timely information but should not be taken as financial or investment advice. Since market conditions can change rapidly, we encourage you to verify information on your own and consult with a professional before making any decisions based on this content.

Solana (SOL) News, Altcoin News, Cryptocurrency News, News

Ibrahim Ajibade is a seasoned research analyst with a background in supporting various Web3 startups and financial organizations. He earned his undergraduate degree in Economics and is currently studying for a Master’s in Blockchain and Distributed Ledger Technologies at the University of Malta.

Ibrahim Ajibade on LinkedIn

Key NotesCardano’s governance vote on a ₳70M Critical Integrations Budget has crossed 53% approval from DReps.ADA price rejected at $0.44 amid broader market recovery, slipping to $0.41 as sell pressure intensifies.Derivatives data shows bulls narrowly retain control, but a $22M short-seller cluster at $0.44 forms a major resistance wall.
Cardano began the weekend under mild pressure, trading just above $0.41 on Saturday, Nov. 29, following a 2% intraday dip that trimmed weekly gains to 3.4%. ADA had touched a weekly high of $0.44 on Thursday as the broader market rebounded, lifted by Bitcoin’s move from $82,000 toward $92,700. 

Momentum slowed shortly after the Cardano team initiated a major governance vote on a Critical Integrations Budget requesting 70 million ADA to fund core infrastructure upgrades. The proposal is now trending toward approval after founder Charles Hoskinson publicly backed the initiative alongside key ecosystem entities, including Input Output HK, EMURGO, Intersect, and Midnight.

The governance action seeks 70 million ADA from the treasury to create a strategic integration fund to onboard tier-one stablecoins, institutional custody solutions, analytics providers, bridges, and pricing oracles. 

Together with @InputOutputHK, @EMURGO_io, @IntersectMBO, and @midnightfdn, we have submitted a governance action to establish a Critical Integrations Budget for Cardano.

If approved by DReps and the constitutionality verified by the Constitutional Committee, the fund will… https://t.co/d0NuU527s0

— Cardano Foundation (@Cardano_CF) November 28, 2025

Supporters argue this is the foundational layer Cardano needs to unlock meaningful growth in DeFi and Real-World Asset activity while pushing the network closer to long-term fee sustainability. 

Voting data reflects a decisive lean toward approval. Delegated representatives (DReps) have cast 2.94 billion ADA, representing 53.14%, in favor. Another 7.89 billion ADA is currently abstaining, while 173.56 million ADA, 3.14%, has been submitted against the proposal. Roughly 2.59 billion ADA, or 43.72%, have not yet voted. 

Among stake pool operators, 237.73 million ADA has been cast in support, with nearly all other voting weight remaining inactive. Constitutional Committee participation currently stands at zero, with all seven members yet to vote. With DReps’ votes crossing the 53% threshold, the governance action is currently on track for approval, though votes remain open until December 30.

Cardano Price Faces Major Sell-Wall at $0.44
ADA now confronts significant resistance at $0.44, where derivatives positioning shows a concentrated short exposure. Coinglass data shows long positions totaling $43 million against $40 million in shorts, indicating bulls still hold a narrow advantage despite the overhead pressure. 

Cardano (ADA) Liquidation Map, Nov 29 | Source: Coinglass

The most notable liquidity pocket sits directly at the $0.44 level, where traders have accumulated $22 million in short leverage. 

Such clusters often act as magnets for volatility and can either trigger rapid forced buying on a breakout or hard rejection when momentum fades. Given current conditions, ADA price remains unlikely to clear the $0.45 barrier without a considerable increase in market volumes.

Disclaimer: Coinspeaker is committed to providing unbiased and transparent reporting. This article aims to deliver accurate and timely information but should not be taken as financial or investment advice. Since market conditions can change rapidly, we encourage you to verify information on your own and consult with a professional before making any decisions based on this content.

Altcoin News, Cryptocurrency News, News

Ibrahim Ajibade is a seasoned research analyst with a background in supporting various Web3 startups and financial organizations. He earned his undergraduate degree in Economics and is currently studying for a Master’s in Blockchain and Distributed Ledger Technologies at the University of Malta.

Ibrahim Ajibade on LinkedIn

Massive Outflows Shake ExchangesXRP liquidity is undergoing significant changes as on-chain data reveals one of the largest synchronized drops across major exchanges. Nearly every top platform reported massive outflows, signaling potential shifts in user behavior and institutional strategies. 

Analysts note that the total XRP held on exchanges has fallen sharply, suggesting either large-scale withdrawals, migration to self-custody, or internal rebalancing. The total exchange-held XRP dropped to 15.86 billion, a decline of 6.5 billion XRP since February, representing a 29% decrease.

Upbit experienced a 6.22 billion XRP outflow, while Binance saw 2.56 billion XRP leave the platform. Bithumb followed with 1.77 billion XRP withdrawn. Other major exchanges, including Uphold, eToro, Bybit, and Bitbank, reported roughly 50% balance drops. 

These figures suggest that users are increasingly moving assets off exchanges, possibly into personal wallets or cold storage solutions. Meanwhile, a few platforms bucked the trend, Evernorth gained 13.36%, Coincheck saw an influx of 550 million XRP, and OKX reported a striking 10,107% spike, likely due to address reclassification.

Conversely, some exchanges faced extreme declines. Coinbase lost 99.97% of its XRP holdings since February, while KuCoin, Paribu, and SwissBorg recorded near-total exits. The widespread reduction in exchange balances highlights a possible reshuffling event that could have long-term implications for XRP liquidity and market dynamics.

This liquidity shift coincides with the upcoming launch of the 21Shares U.S. spot XRP ETF, set to trade under the ticker TOXR on Monday. The ETF will track the CME CF XRP-Dollar Reference Rate, allowing investors exposure to XRP’s spot price without holding the cryptocurrency directly. 

The U.S. market has seen a flurry of XRP ETF activity in recent days, including launches from Grayscale and Franklin Templeton. Early trading of these ETFs shows strong demand, with GXRP and XRPZ capturing $67.36 million and $62.59 million in flows on their first days, respectively.

Technical Outlook: Key Levels to WatchSource: X

As of press time, XRP’s price rose 0.75% in the last 24 hours, trading at $2.19, with a 7-day gain of 13.61% and a market cap of $132 billion. According to EGRAG CRYPTO analysis, closing above $2.60 could signal bullish momentum, while surpassing $3.40 would indicate strong upward trends. 

Conversely, a close below the 21 EMA may mark a bearish reversal. Analysts emphasize monitoring these levels for signs of sustained market strength.

ConclusionXRP’s recent exchange outflows, combined with the launch of the 21Shares ETF, indicate a transformative period for liquidity and investor behavior. Large-scale withdrawals, inflows, and technical benchmarks highlight both risk and opportunity. Traders should monitor exchange balances, ETF activity, and technical levels closely, as XRP navigates this pivotal phase in its market evolution.

Avalanche has entered a new phase of strength after breaking through a stubborn resistance level that previously held the price below $15. The decisive move has shifted momentum in favor of buyers and opened a pathway toward a potential climb to $15.5, reinforcing confidence at a time when sentiment across the altcoin market has been inconsistent.

Solana has been one of the standout performers in institutional markets over the past month, driven largely by an uninterrupted stream of capital flowing into its exchange-traded funds. That narrative shifted for the first time in 22 trading days after TSOL, the 21Shares Solana ETF, recorded a substantial outflow that pushed total SOL ETF flows into negative territory.

Bitcoin has one advantage no other cryptocurrency can match.

In my view, Bitcoin (BTC 0.27%) remains the best cryptocurrency to own over the next 100 years. While other investors get involved in other cryptocurrencies, including altcoins and meme coins, there's one reason you should never give up on Bitcoin.

Today's Change

(

-0.27

%) $

-248.13

Current Price

$

90809.00

Bitcoin will forever be digital gold
It is very rare for an asset to be considered a global store of value. A store-of-value asset is exactly what it sounds like -- investors can reasonably expect it to maintain its value in a variety of conditions. From war and famine to years of plenty, these assets have continually shown that they can outlast temporary volatility.

What are some examples? The most popular are land, collectibles, gold, and other precious metals. Notice something similar about these assets? While more land may be developed, more collectibles identified, and more gold mined, the total quantity of each can never increase.

The amount of available land will be the same 100 years from now. And while collectibles are still being created, they aren't making any more wine bottled in the 1700s, nor are they producing more 1960s classic cars. Whatever there is today is all there ever will be. The same is true for gold and other precious metals. More may be mined, but more can't be created.

Image source: Getty Images.

With stock markets trading at very high valuations, investors are wise to seek out alternative assets, such as land, collectibles, and precious metals like gold. Bitcoin should be near the top of that list. Yes, more Bitcoin is mined every day. But there's a limit to how many coins can exist. The maximum long-term supply is 21 million, and 19 million have already been mined. This makes Bitcoin a scarce asset, similar to other store-of-value assets.

Gold has been valued by humans for thousands of years. Land, of course, has been valued by humans since the dawn of time. Very rarely do new assets appear that have global recognition of value simply by existing. 

Bitcoin is one of those assets. And while its history is relatively short, Bitcoin's total market cap reflects this reality. The total value of land globally is at least several hundred trillion dollars. Gold, meanwhile, has a market cap of around $24 trillion. Bitcoin, however, has a total market cap of under $2 trillion.

There's a lot of room for Bitcoin to run compared to gold's long history. And while there may be a lot of volatility along the way, Bitcoin's total supply cap continues to make it a multidecade holding.

Pi Coin price has held up better than most majors through November, but the charts now show a mix of strength and early warning signs. November has been Pi’s calmest month since summer, and the token is still trying to turn green for only the third time this year.

The question now is whether this momentum can survive December, even do better than November, or if the larger downtrend reclaims control.

Sponsored

Sponsored

History And Its Negative Correlation With BitcoinPi Coin is still young, so its price history leaves a short but clear story. Most of 2025 has been red. Only February and May printed green months. November is trying to join that list.

Price History: CryptoRankWant more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

What stands out is PI’s negative monthly correlation with Bitcoin, currently around –0.24. When Bitcoin drops, Pi often holds firmer or even rises. Since Bitcoin has been weakening since October, Pi has found support.

Over the last month, Pi is down only about 2.6%, while Bitcoin has dropped much more sharply. Almost 19%.

Pi Coin- BTC Correlation: DeFillamaWeekly performance also reflects this. Pi is still up about 2.7% over the last seven days, making it one of the steadier coins during a weak market. However, some signals on the three-day chart now suggest that December could be more challenging than November.

Sponsored

Sponsored

Pi Coin’s broader structure remains inside a converging falling wedge, which is usually a bullish pattern. The PI price is now close to the upper trendline of that wedge. A breakout from here would normally look positive. But two indicators show early weakness.

The first is the RSI divergence on the three-day chart. The RSI, or Relative Strength Index, measures momentum. Between October 25 and November 24, Pi Coin made a lower high, but RSI made a higher high. This is a hidden bearish divergence. It usually means the downtrend underneath is still strong, even if the price looks stable.

Pi Coin Faces Divergence Risk: TradingViewThe second is the CMF, or Chaikin Money Flow, which tracks whether large amounts of money enter or exit the market. CMF is still in negative territory on the three-day chart and is now sliding toward its ascending trendline.

Sponsored

Sponsored

The last time CMF revisited this trendline in early October, Pi dropped more than 42%.

Big Money Keeps Flowing Out: TradingViewBoth signals together mean that PI’s November strength may not fully translate into December unless money returns and CMF avoids a breakdown.

Pi Coin Price Levels To Watch In DecemberThe chart shows a simple picture. PI price needs to break $0.28 to build momentum. That level lines up with the wedge’s upper boundary.

Sponsored

Sponsored

A clean close above $0.28 can open moves to $0.36, and if momentum improves further, even $0.46 becomes possible. But the indicators suggest this is less likely unless CMF improves.

On the downside, $0.21 and $0.20 are the first levels to watch. A drop under $0.20 exposes the $0.18 zone. If Bitcoin suddenly flips bullish, PI’s negative correlation can cause short-term underperformance. That may pull the Pi Coin price toward the lower wedge band.

Pi Coin Price Analysis: TradingViewThe most important line for December is $0.20. Maintaining that level preserves the long-term structure. Losing it brings $0.18, and possibly $0.15, back into view.

Pi Coin still has a chance to close the year stronger than expected. However, that depends entirely on CMF stabilizing and whether the falling wedge finally allows the price to break through $0.28.

There is hope still if Bitcoin weakens and the negative correlation makes Pi Coin more desirable to big money.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

The Bitcoin, Ethereum, and XRP prices are showing signs of recovery as traders across regions take sharply different approaches to the latest price swings. Fresh market data reveals that buying and selling pressure is no longer evenly distributed throughout the day, with the United States emerging as the key source of support. At the same time, other regions struggle to regain a solid footing. 

US Traders Fuel Bitcoin, Ethereum, And XRP Price Recovery
Bitcoin’s market has moved once again as fresh on-chain data shows a clear divide in buying and seeking across global trading hours. A recent shift in US trading activity has had a noticeable impact on the broader crypto market. Ethereum and XRP, which experienced a sharp decline in previous weeks, have begun to stabilize and show mild recovery as Bitcoin strengthens during US hours. 

Currently, the price of BTC is above $90,000 after crashing below $87,000 earlier in the week. Ethereum has also reclaimed the $3,000 level and is now trading steadily above it. XRP has recorded the most weekly increase between the two, jumping approximately 14% according to CoinMarketCap, with its price presently around $2.18. While these cryptocurrencies have yet to regain all lost ground, renewed buying from US traders has helped ease the downward momentum that dominated in previous weeks. 

Sharing a new session-based chart from Velo, market analyst Ted Pillows disclosed that the US has reemerged as a net buyer of Bitcoin. At the same time, Asia remains the primary source of selling pressure throughout the year. This regional imbalance has reshaped the latest price movements of Ethereum and XRP, which tend to follow Bitcoin’s upward trajectory. 

The latest figures from Velo support this view. Velo’s Bitcoin session chart shows that US trading hours, which had been in negative territory earlier in the week, climbed steadily into positive territory from November 24 to date. The blue line representing US hours rose from just above 2% to 3.73% on November 24 before reaching 7.55% by November 26. This reflects a gain of more than 4% over the period, confirming a strong resurgence in demand from US traders. 

Europe Remains Uneven While Asia Leads Bitcoin Selling 
European trading hours, highlighted by the purple line, have been more uneven than those of the US. Europe rose to 1.67% on November 24 and briefly pushed higher to 3.31% later that day. This surge comes after the cumulative weekly return fell into negative territory from November 21, and while a slight recovery followed, it still ended the week below the flat line. This suggests that despite weak buying momentum, Europe may no longer be delivering the heavy selling pressure seen earlier. 

On the other hand, Asia continues to lag behind both regions. Velo’s chart shows that the APAC trading session, represented by the yellow line, started in slightly positive territory around November 20 but turned negative soon after. For most of the week, the regions remained between -5% and -7%. This persistent weakness signals a continuation of the year-long pattern in which Asian hours have been the leading driver of Bitcoin’s sell-side pressure.  

Featured image from Unsplash, chart from TradingView

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter!
For updates and exclusive offers enter your email.

Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts.
Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.

Alphabet is at a crossroads, and Gemini could be the answer to its future.

Alphabet (GOOGL +0.06%) (GOOG 0.05%) is standing at a crossroads. For more than 20 years, it has dominated how people search, learn, and navigate the internet. However, the rise of generative AI is reshaping user behavior faster than any technology shift since the advent of smartphones.

Alphabet's answer is Gemini, a unified family of AI models built to power everything from Google Search to YouTube, Android, Workspace, and Google Cloud. The question for long-term investors is simple: Can Gemini fundamentally change Alphabet's trajectory, or is it merely the next iteration of Google's AI efforts?

The answer is likely nuanced rather than straightforward. Let's dive in.

Image source: Getty Images.

Gemini's strength comes from its reach across Alphabet's ecosystem.
Unlike previous AI models that were confined to isolated products, Gemini sits at the center of Alphabet's entire ecosystem. It powers search, supports creator tools within YouTube, runs writing and productivity features within Workspace, and increasingly shapes the intelligence layer within Android and Chrome. It also underpins many of the AI services offered through Google Cloud.

This integrated approach is a significant strategic advantage. Alphabet can distribute new AI capabilities instantly to billions of users without needing to build adoption from scratch. Gemini does not have to outperform rival models on technical benchmarks to be commercially valuable. It needs to make Google's products more useful, stickier, and more monetizable.

For example, better search answers increase user satisfaction, improved targeting makes advertising more efficient, and more innovative productivity tools help Alphabet deepen its foothold in the enterprise software market. In short, Gemini's true leverage lies in the scale of Alphabet's ecosystem, not solely in model quality.

Today's Change

(

0.06

%) $

0.19

Current Price

$

320.14

Gemini helps Alphabet defend its moat
Alphabet's strongest business -- search -- faces long-term structural pressure as more people experiment with AI assistants to answer questions, summarize information, or perform tasks directly. This shift challenges the traditional "query to results to ad click" flow that built Google's economics.

Gemini is Alphabet's attempt to modernize search from the inside out. By making search more conversational, context-aware, and capable of generating direct answers, Alphabet can adapt to changing user behavior while keeping users inside its ecosystem. This move matters because competitors like OpenAI or Perplexity have no incentive to preserve the old search model. They can build AI-first experiences without worrying about cannibalizing billions of dollars in ad revenue.

Alphabet, however, must innovate without destabilizing its core profit engine. Gemini allows Google to move faster without undermining its monetization model. It strengthens user retention, improves the quality of results, and gives Alphabet a competitive edge in shaping the evolution of AI-driven search. While this doesn't eliminate the risk of long-term behavioral changes, it gives Alphabet a far stronger defensive position than many fear.

The most significant commercial opportunity is probably Google Cloud
Much of the public attention focuses on Gemini inside Search or Android, but the most meaningful financial impact could emerge from enterprise adoption through Google Cloud. Notably, with the introduction of Gemini Enterprise, Alphabet offers a full-stack approach to AI, covering everything from infrastructure to products and platforms.

Gemini supports a wide range of enterprise use cases, including AI-assisted development, automated workflows, advanced data analytics, custom model training, and enhanced productivity features within Workspace. If enterprises adopt Gemini widely, Google Cloud could gain market share, improve margins, and, most importantly, develop into a second major profit engine for Alphabet.

This shift would significantly reduce Alphabet's reliance on advertising cycles and create a more balanced, durable business model. For investors, this is where Gemini's long-term value truly compounds.

But Gemini doesn't guarantee Alphabet's transformation
The bullish narrative is compelling, but investors should recognize the real risks. AI-native competitors may innovate faster. Enterprises might prefer open-source or lower-cost models. Consumer AI features could unintentionally reduce the volume of monetizable search queries. Google Cloud may struggle to gain sufficient adoption and have a meaningful impact on Alphabet's profit profile.

In that scenario, Gemini becomes a necessary defensive tool rather than a catalyst for accelerated growth. Alphabet would remain a strong company, but the AI transition would deliver only incremental improvements rather than a step-change in performance.

What does it mean for investors?
Gemini represents one of the most ambitious and strategically important AI efforts in Alphabet's history. It gives the company a path to modernize search, reinforce user loyalty across billions of devices, and compete meaningfully in enterprise AI. But its potential depends on whether Alphabet can execute across all of these fronts, defending its core business while expanding into new ones.

The upside is clear: Gemini could help Alphabet extend its dominance well into the next decade. The risk is equally clear: if execution falters, Gemini simply helps Alphabet keep pace. How Alphabet navigates this transition will shape the next chapter of one of the world's most important technology companies.

Which one of these two high-flying necloud companies should you consider buying right now?

CoreWeave (CRWV 1.57%) and Nebius Group (NBIS +0.19%) are two companies that have been growing at an incredible pace owing to their business model. These companies are in the business of building data centers capable of running artificial intelligence (AI) workloads and renting them out to hyperscalers, AI companies, or anyone looking to buy dedicated AI data center capacity.

Formally known as neocloud companies, both CoreWeave and Nebius have seen incredible jumps in their stock prices this year. While CoreWeave is up 84% since its initial public offering (IPO) in late March this year, Nebius stock has shot up a stunning 231% this year. But if you had to choose from one of these two neocloud stocks for your portfolio right now, which one should it be?

Let's find out.

Image source: Getty Images.

The case for CoreWeave
CoreWeave went public toward the end of March, and it was the biggest tech IPO in the U.S. since 2021. Shares of the company rose impressively over the next few months and hit a high on June 20. However, it has been all downhill for CoreWeave since then, with the stock losing over 60% of its value.

CoreWeave investors got another shock recently after the company released its third-quarter results. Though it reported massive year-over-year growth of 134% in its revenue to $1.36 billion, CoreWeave had to slightly reduce its full-year guidance. It now expects full-year revenue to land at $5.1 billion at the midpoint of its guidance range, down from the earlier estimate of $5.25 billion.

The company had to trim its guidance because of a delay in the delivery of data center capacity by a third-party developer. CoreWeave said that this delay is temporary, and the impacted customer has agreed to maintain the total contract value and has adjusted the delivery schedule. So, this is a short-term impact that CoreWeave should be able to overcome.

Today's Change

(

-1.57

%) $

-1.17

Current Price

$

73.12

Importantly, CoreWeave's long-term growth story remains intact. That's evident from the company's massive revenue backlog of just under $56 billion at the end of the previous quarter. CoreWeave was sitting on a backlog of $15 billion a year ago, so this metric almost quadrupled. The massive leap in CoreWeave's backlog can be attributed to the ever-growing demand for AI compute capacity.

The company has received massive contracts from Meta Platforms, OpenAI, and other hyperscalers who are looking to purchase AI compute capacity. As a result, CoreWeave is bringing new capacity online at an aggressive pace. It increased its contracted data center power capacity by 600 megawatts (MW) to 2.9 gigawatts in Q3.

Additionally, it brought online 120 MW of new capacity in Q3. CoreWeave had a total active data center capacity of 590 MW at the end of the previous quarter. The contracted capacity makes it clear that CoreWeave is on track to bring online more capacity, and that should allow it to convert its sizable backlog into revenue.

Another thing worth noting here is that CoreWeave has built a diversified customer base. It now has 10 large customers, thereby reducing its reliance on one or two names, and almost all of them have signed multiple contracts with CoreWeave. So, this AI stock seems primed to regain its mojo, and the huge demand for AI computing power should ensure that it keeps growing at a terrific pace in the long run.

The case for Nebius
Just like CoreWeave, even Nebius is getting massive contracts from customers such as Microsoft and Meta. Though Nebius is a relatively small company when compared to CoreWeave, it can scale up quickly thanks to its recent deals.

Today's Change

(

0.19

%) $

0.18

Current Price

$

94.87

The company's Q3 revenue was up by a whopping 355% year over year to $146 million. The multibillion-dollar contracts that Nebius has signed of late suggest that its remarkable growth is sustainable. Microsoft awarded a deal worth $17.4 billion to $19.4 billion to Nebius in September to purchase AI compute capacity from the latter over a five-year period.

Meta has also joined the company's client list with a five-year contract valued at $3 billion. Nebius, therefore, is sitting on a revenue backlog of more than $20 billion. Fortunately, Nebius is now going to boost its data center capacity at a faster pace.

The company was earlier expecting to have 1 GW of contracted data center capacity at its disposal by the end of 2026. It has now bumped up that target to 2.5 GW. Even better, Nebius plans on boosting its active data center capacity from an estimated 220 MW at the end of 2025 to a range of 800 MW to 1 GW by the end of next year.

So there is a good chance of Nebius clocking much faster growth in revenue going forward, and that's what even analysts are expecting from the company.

Data by YCharts.

The verdict
Clearly, both CoreWeave and Nebius are high-growth companies that can help investors capitalize on the AI infrastructure boom. However, when it comes to choosing one of these stocks, there is a clear winner.

Data by YCharts.

CoreWeave stock trades at a significantly cheaper sales multiple right now. In fact, it can be bought at a discount to the U.S. technology sector's average price-to-sales ratio of 8.4, despite its stunning growth. Moreover, CoreWeave has a more diversified customer base and a much bigger backlog, while much of Nebius' growth is currently dependent on just two customers.

Of course, even Nebius can turn out to be a solid investment in the long run, but if you're looking to choose from one of these two neocloud companies right now, CoreWeave looks like a better buy from a valuation standpoint.

The telecom is committed to shoring up its balance sheet. Now may be a good time for investors to buy in.

Telecommunications company Lumen Technologies (LUMN +0.25%) has been working to turn around its fortunes for more than a decade now. Management knows that turning around a company of its size financially is like steering a large ship away from an iceberg. If the company, led by CEO Kate Johnson, fails to execute, that could spell real doom and gloom. Yet, if leadership can slowly and consistently turn away from distress, the upside for investors down the road could be more than substantial.

A look at Lumen's third-quarter earnings report shows it is, in fact, avoiding disaster and heading to calmer waters. But the days of smooth sailing are still somewhat in the distance: Think 2028 or even 2030.

There is also still plenty of risk; the company carries about $17.5 billion in debt, a significant load compared to its revenue of $9 billion in the first three quarters of the fiscal year. Lumen's legacy business is on the decline as well.

On the flip side of those challenges are new business partnerships, a bold and clear vision for the digital future, and the successful restructuring of much of Lumen's debt.

Image source: Getty Images.

Lumen needs lower interest rates
Lumen Technologies (formerly CenturyLink) is a telecom offering various communication services, including network, security, cloud, and voice through its fiber optic and copper networks, data centers, and cloud computing services. It's been around for decades under different names and went public in 1978.

Of late, Lumen has been fighting an uphill battle to compete with the larger telecoms and has had limited success in the last couple of years. Lumen's investors will be rewarded if interest rates continue to fall and the company can refinance its debt over the coming years.

Its third-quarter results showed a savings of $135 million in annual interest expense year to date. This demonstrates real progress and a commitment to shareholders to improve its balance sheet. The overall debt total decreased from its peak of $37 billion in 2017 to the aforementioned $17.5 billion.

In September, management highlighted how it would improve growth metrics. Johnson said the company is seeking to become the backbone of the artificial intelligence (AI) economy. To do this, it will focus on delivering connectivity through its existing physical network. The business will also work to simplify the network for its customers and create partnerships within an ecosystem to extend Lumen's reach.

The company's sale of its home-fiber business to AT&T is expected to close in early 2026 for $5.75 billion, allowing Lumen to focus more on its enterprise solutions while simultaneously improving its balance sheet.

Besides that upcoming sale, improvements in its liabilities and new partnerships with Palantir and Microsoft should help strengthen its place among the large players in enterprise AI. This progress in the business's fundamentals might not have material effects on the stock price in the short term, but over the next several years, it could really bolster the shares.

For those reasons, Lumen's stock could appeal to investors who like to buy into turnaround plays. Currently trading halfway between its 52-week low and high, shares will be undervalued if the turnaround continues to progress.

Today's Change

(

0.25

%) $

0.02

Current Price

$

8.11

A lot of pressure on its balance sheet
Should interest rates remain the same or push slightly higher, Lumen will struggle to keep up with both its obligations and the capital required for the necessary modernization of its fiber network. The execution risks combined with an uncertain economy make the path to a full turnaround have some significant hurdles, which investors should not ignore.

An undervalued company, if it can stay the course
Lumen isn't a juggernaut compared to its counterparts, AT&T and Verizon Communications. That's not necessarily a bad thing, though. It has room to grow and can be a bit more nimble when it comes to its partnerships and diversifying revenue.

The company's transformation is still early on, but for those willing to wait at least a couple of years, it deserves a second look. If investors are confident that interest rates are going to fall and the company's leaders can continue improving its balance sheet while growing alongside the AI economy, Lumen is currently undervalued.

November 29, 2025 5:00 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 29, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zions Bancorporation, N.A. (NASDAQ: ZION) (NASDAQ: ZIONP) resulting from allegations that Zions Bancorporation may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Zions Bancorporation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=46354 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On October 15, 2025, Zions Bancorporation announced that it would be taking a $50 million charge-off for a loan underwritten by its wholly-owned subsidiary, California Bank & Trust, in light of "apparent misrepresentations and contractual defaults by the Borrowers and Obligors and other irregularities with respect to the Loans and collateral." Zions Bancorporation further disclosed that it would be engaging counsel to coordinate an independent review of the matter.

On this news, Zions Bancorporation's common stock fell 13.14% on October 16, 2025.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276295

Tesla stock has been on a roller coaster ride in recent years. How has it done for investors?

Tesla (TSLA +0.82%) stock has taken its investors on a wild ride over the last five years. Since November of 2021, shareholders have been treated to huge price jumps of more than 75%, and dizzying stock price drops of more than 50%.

But how has Tesla done for investors who bought in at other times? And how has that compared to the overall stock market? The answers may surprise you.

1 year or less: a mixed bag
Investors who bought Tesla shares a year ago in the wake of the 2024 presidential election -- in which Tesla CEO Elon Musk played a major role -- should be happy with their returns. The shares are up 25% from then to now, which beats the S&P 500's 14.5% total return over the same time period.

Image source: Tesla.

However, for much of the year, those investors were not only losing out to the broader market, but underwater on an absolute basis. Tesla's shares fell as much as 37% from their November 2024 prices in April 2025, as Musk's controversial political activities generated intense publicity that affected public perception of the company. They didn't return to market-beating status until September.

Today's Change

(

0.82

%) $

3.51

Current Price

$

430.09

Tesla's all-time high closing price of $479.86 a share came on Dec. 17, 2024, just a few weeks shy of a year ago. If you'd bought Tesla stock on that day at that price, you'd be losing to the market by about 25 percentage points instead of leading it by nine. That's how wild Tesla's recent price swings have been.

3 & 5 years: almost identical
If you'd invested in Tesla three years ago, on Nov. 25, 2022, when the stock closed at $182.86/share, you'd be decisively beating the market right now, with a total return of 131% to the market's 75.5%. However, you would have had to weather a stomach-churning 40% drop in the share price before the end of 2022, and you would have spent most of 2024 losing to the market.

Surprisingly, if you'd bought shares of Tesla two years earlier, during the COVID-19 pandemic lockdown era on Nov. 25, 2020, your five-year performance would be almost identical to your three-year performance: 131% vs. 122%. That's because Tesla shares went way up in 2021, and way back down in 2022.

The big difference is that the market's returns are 21 percentage points better at the five-year mark, up almost 101%. So while Tesla stock is currently beating the market by about 21 percentage points over the five-year period, it's spent much more of the last three years losing to the market than the three-year position has.

The power of time
Obviously, beating the market -- especially such a robust bull market -- by any amount is a good thing, but the longer you hold an investment, the likelier it is to generate clear market-beating returns.

Case in point: The five-year returns on a Tesla investment are a very strong 122%, but the six-year returns are a jaw-dropping 1,790%, destroying the S&P 500's 137% return. Tesla's pre-2020 investors have never even come close to losing to the market at any time over the last five years, demonstrating the power of buying and holding.

Warren Buffett's company, Berkshire Hathaway, runs a large equities portfolio valued at over $300 billion.

One thing I've always admired about Warren Buffett, outgoing CEO of Berkshire Hathaway, is that throughout his remarkable career, he has consistently adhered to his core investing principles without becoming entrenched in his old ways. Buffett and his team have never been afraid to invest in newer sectors.

While Berkshire isn't buying pure artificial intelligence stocks, the company (at the direction of Buffett) has purchased several stocks in the "Magnificent Seven" during a time when many investors are concerned about the sheer size of these companies and their dominance of the broader market. In fact, nearly 24% of Berkshire's massive, roughly $305 billion equities portfolio is invested in just these three stocks.

Image source: Getty Images.

1. Apple: 21.3%
Berkshire first invested in consumer tech giant Apple (AAPL +0.46%) in 2016 and at one point had grown the position to roughly 40% of Berkshire's portfolio. Buffett supposedly first got interested in the position after seeing how devastated one of his friends was after losing their iPhone.

Apple has many of the characteristics that Buffett typically looks for in a stock: a rock-solid moat, a strong brand, tremendous earnings power, and it has repurchased a lot of stock over the years.

While a part of the Magnificent Seven, many investors have been concerned about Apple's AI strategy. But at some point, the company is likely to become a tremendous beneficiary of the technology, at the very least as it integrates AI features into its consumer products.

Today's Change

(

1.77

%) $

4.06

Current Price

$

233.22

While Apple is still Berkshire's largest position, Berkshire has sold 74% of its stake in the company since early 2023. Buffett and Berkshire have seemingly been very worried about the market, so it makes sense they would want to reduce their exposure to one of the biggest stocks in the market. I think it's likely Berkshire will eventually exit the position.

Apple has actually proven to be a decent stock to own during the AI sell-off because it hasn't invested as heavily in AI infrastructure as some of its peers, making those worried about a bubble less concerned with the company. I believe it's a stock that investors can still hold for the long term.

2. Alphabet: 1.8%
Berkshire initiated a new position in Alphabet (GOOG 0.05%)(GOOGL +0.06%) during the third quarter, a stock that seemed to be a popular pick among hedge funds. Google has had a bumpy year, but ultimately seems to have emerged better. The U.S. Department of Justice (DOJ) sued the large tech conglomerate, alleging that Google employed monopolistic practices in the search and digital advertising markets to maintain its dominant position.

A federal court agreed with the DOJ, but ultimately issued a weaker punishment than most expected, essentially allowing the company to continue operating as usual. Alphabet has also been able to shake off concerns about AI chatbots, such as OpenAI's ChatGPT, creeping into the search space, with its own innovations like Google overviews and AI mode. The company also recent released the third version of its AI model.

Today's Change

(

-0.05

%) $

-0.15

Current Price

$

320.13

It's easy to see why the smart money likes Alphabet right now. The stock trades at about 30 times forward earnings. It's a play on AI, but also has many other strong business with strong growth potential like Google Cloud, YouTube, and Waymo, among others.

On a sum-of-the-parts valuation, I am confident that the company is worth significantly more than its current market capitalization.

3. Amazon: 0.7%
Berkshire first purchased Amazon (AMZN +1.77%) in 2019, although the stock only makes up a small portion of Berkshire's portfolio.

Amazon owns two phenomenal businesses. The first is the one most people interact with on a daily or weekly basis: the retail e-commerce business, where consumers can buy almost any product and have it shipped to their door in just a few days or even the very next day. The company bundles this business and other ancillary services, such as Prime Video, to sell its annual Amazon Prime subscription, which generates recurring annual revenue.

Today's Change

(

1.77

%) $

4.06

Current Price

$

233.22

Amazon also operates a large cloud business called Amazon Web Services (AWS), which enables businesses to rent Amazon's extensive network of servers to store their data in the cloud and utilize other tools that help them run more efficiently. In the second quarter of 2025, AWS led the global cloud market with 30% market share.

I think what many fail to understand is that even before AI, AWS still had a significant runway to convert businesses to the cloud. Naturally, though, any big cloud player is going to be a big beneficiary of AI.

Amazon trades about 32 times forward earnings, which suggests the stock is not cheap. Still, no company in the Magnificent Seven necessarily trades cheap, but plenty of investors are OK these valuations, consider the still solid growth potential these companies have for reasons related to AI as well as for their incredibly strong non-AI businesses.

These stocks have been raising their dividend payments annually for well over a decade, and they pay more than twice the S&P 500 average.

Want some quality income-generating investments you can put in your portfolio for the long term, and not worry about? The stocks listed below check off those boxes and can make for ideal investments to buy and hold. Not only do they offer high yields today, but they've also been growing their payouts for decades.

AbbVie (ABBV +0.02%), Home Depot (HD +0.41%), and ExxonMobil (XOM +1.00%) can diversify your portfolio while also setting you up to generate plenty of recurring cash flow for the long term. Here's a closer look at them, and why they're among the best dividend stocks you can buy today.

Image source: Getty Images.

AbbVie
Pharma stock AbbVie pays investors a yield of around 2.9% right now, which is more than double the S&P 500 average of 1.2%. The company spun off from Abbott Laboratories back in 2013, and when including its streak as part of that business, it spans more than 50 straight years, which means AbbVie is a Dividend King.

The company's most recent increase is a 5.5% boost to its payout in light of its strong financial results. Since splitting off from Abbott Labs, AbbVie has increased its quarterly dividend payments by over 330%. AbbVie hasn't simply been boosting the dividend to keep its streak going; it has been making meaningful rate hikes for its shareholders.

Today's Change

(

0.02

%) $

0.04

Current Price

$

227.70

Through the first nine months of the year, the company has demonstrated strong growth with sales rising by 8%, to $44.5 billion. Humira is no longer its top-selling drug, but AbbVie has been able to pivot to other drugs, with Skyrizi and Rinvoq generating a combined $18.5 billion through the first three quarters, well above Humira's current quarterly tally of $3.3 billion.

With a diverse mix of drugs treating various diseases and conditions, AbbVie is one of the most robust and safest dividend stocks you can find in the healthcare sector.

Home Depot
Home improvement giant Home Depot is another top dividend growth stock to buy and hold. While it may not have the impressive growth streak that AbbVie has going, it has been raising its dividend for 16 straight years. And since 2020, its quarterly dividend has grown by more than 50%.

It's currently yielding 2.7%, which is a solid rate for the retailer. The business is facing challenges as discretionary spending has been down amid challenging economic conditions. But what's encouraging is that the company still expects sales growth of 3% for its current fiscal year (it ends in January).

Today's Change

(

0.41

%) $

1.45

Current Price

$

356.92

Shares of Home Depot are down 13% this year as investors worry about troubling results ahead. But the home improvement retailer should recover in the long run, as it's a top name in home repair. Spending money on repairs and maintenance around the house can be put off temporarily, but it's also an inevitability that comes with home ownership, which is why I'm confident it can bounce back from any downturn, as it has in the past.

ExxonMobil
From healthcare to retail to now oil and gas, ExxonMobil is a stock that can help balance out and diversify your portfolio. Its 3.5% yield is the highest one on this list. As a leading oil and gas producer, ExxonMobil has the strength to take on myriad challenges and still generate strong results and grow its dividend.

Its dividend has grown on an annual basis for 43 consecutive years, at an average rate of 5.8%. Despite volatility in commodity prices, for decades, the company has demonstrated some excellent financial strength. This year, there has been some volatility in its bottom line as ExxonMobil's earnings have declined by $3.7 billion, to $22.3 billion thus far. But with earnings per share of $5.16 during that stretch, that's already more than what the company pays in dividends for an entire year -- $4.12.

Today's Change

(

1.00

%) $

1.15

Current Price

$

115.92

ExxonMobil's earnings may seem shaky and volatile, but the company can afford to handle the uncertainty and still provide investors with a growing dividend over the long term. The stock is up 8% this year, and it trades at an estimated 16 times its future earnings (based on analyst estimates), making it a good value option for income investors to buy and hold.

Investors are failing to take the long view on this stock as it trades at a cheap price, compared to its earnings potential.

Right now, all investors want to focus on are growth stocks, especially anything related to artificial intelligence (AI). This is turning attention away from opportunities in value stocks, which investors should take advantage of as the calendar turns to 2026.

One beaten-down stock that is trading at its lowest cash-flow multiple in five years is Crocs (CROX 0.56%). Here's why the eccentric shoe brand may be the best value stock you can buy before 2026.

Today's Change

(

-0.56

%) $

-0.48

Current Price

$

84.98

Declining sales and a reset opportunity
Crocs experienced tremendous growth during the COVID-19 pandemic, spurred by the growing trend of casual wear around the globe. There's no denying that the brand has hit a bit of a rough patch, accelerated by the poor timing around the acquisition of the HeyDude shoe brand.

Revenue for Crocs declined 3% year over year last quarter to $836 million, with HeyDude down 22% to $160 million. Since the middle of 2023, Crocs trailing twelve month revenue -- revenue over the preceding four quarters -- has hovered around $4 billion and is now moving in the wrong direction.

This is the key reason why Crocs stock is in a 56% drawdown. While it would be better if the brand could produce steady growth year after year, investors looking at Crocs today should think of the last few years as a reset after its monstrous growth in the years prior.

What's more, Crocs is doing well outside of North America, which is driving more sales growth. International revenue increased 6% last quarter to $389 million. The Crocs brand is growing globally and has been a mainstay in casual and aquatic apparel in the United States for decades.

Image source: Getty Images.

Returning cash at a discounted valuation
With the stock in a massive drawdown, Crocs now trades at a discounted price, relative to its cash-flow generation. Free cash flow per share is now $12.77 and has been above $10 since 2023. With a stock price of $80, Crocs trades at a trailing price-to-free cash flow ratio (P/FCF) below 7.

Management is accelerating its share repurchases at these discounted prices, which will benefit long-term growth in free cash flow per share and drive the stock price higher. Shares outstanding have fallen by 20% in the last five years at an accelerating rate. At current stock-price levels, Crocs will be able to further accelerate the pace of the decline of shares outstanding, which any shareholder should applaud.

CROX shares outstanding data by YCharts.

Why Crocs is a great value stock for 2026
Crocs is trading like the business is heading for the dustbin of history at just over 6x its trailing-cash-flow levels. Investors are pricing in many years of declining revenue ahead, similar to the last quarter.

This puts too much doubt on the business and gives no credence to a potential turnaround in fortunes for the eccentric maker of sandals. While the apparel business is never linear, Crocs has proven time and time again that it can stay relevant for consumers in the United States and is now growing across the world.

If Crocs can regain its mojo and begin to grow again, the business will start spitting out growing revenue and free cash flow, and the stock will likely begin to trade at a higher multiple of earnings. If it keeps struggling to grow, then the capital returns program and low starting valuation will provide downside protection.

This is a great opportunity with low downside risk but lots of upside potential for those looking to buy Crocs stock today. Therefore, it's the perfect value play for investors in 2026.